| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0045 | 1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.01 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |